Estimating the health and economic effects of the proposed US Food and Drug Administration voluntary sodium reformulation: Microsimulation cost-effectiveness analysis

BACKGROUND: Sodium consumption is a modifiable risk factor for higher blood pressure (BP) and cardiovascular disease (CVD). The US Food and Drug Administration (FDA) has proposed voluntary sodium reduction goals targeting processed and commercially prepared foods. We aimed to quantify the potential...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS Med
Autors principals: Pearson-Stuttard, Jonathan, Kypridemos, Chris, Collins, Brendan, Mozaffarian, Dariush, Huang, Yue, Bandosz, Piotr, Capewell, Simon, Whitsel, Laurie, Wilde, Parke, O’Flaherty, Martin, Micha, Renata
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5892867/
https://ncbi.nlm.nih.gov/pubmed/29634725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.1002551
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars